Lv53
1430 积分 2024-01-29 加入
Progressive metastatic infantile fibrosarcoma with multiple acquired mutations
21天前
已关闭
Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion–Positive Solid Tumors (Children's Oncology Group ADVL1823)
26天前
已关闭
Regulating Tumorigenicity and Cancer Metastasis through TRKA Signaling
27天前
已完结
Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
27天前
已完结
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer
1个月前
已关闭
Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial
1个月前
已完结
EXTH-80. PBI-200: IN VIVO EFFICACY OF A NOVEL, HIGHLY CNS-PENETRANT NEXT GENERATION TRK INHIBITOR
1个月前
已关闭
A phase II basket study of the oral TRK inhibitor LOXO–101 in adult subjects with NTRK fusion-positive tumors
1个月前
已关闭
2013P Repotrectinib in adult and pediatric patients with NTRK+ advanced solid tumors: Updated results from the TRIDENT-1 and CARE trials
1个月前
已关闭
Off-target resistance to larotrectinib in two patients with NTRK fusion-positive pediatric solid tumors
1个月前
已完结
皖公网安备34019202002308